Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer
Welcome introduction and objectives and Treatment for locally advanced/metastatic cutaneous squamous cell carcinoma (CSCC)
Date
22 Sep 2020Session
Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancerPresenters
Chrysalyne SchmultsAuthors
C.D. SchmultsAuthor affiliations
- Department Of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Harvard/US
Resources
Resources from the same session
Emerging research with immune checkpoint inhibitors in basal cell carcinoma (BCC)
Presenter: Susana Puig
Session: Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer
Resources:
Webcast
Exploring the emerging research with immuno-oncology in CSCC
Presenter: Dirk Schadendorf
Session: Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer
Resources:
Webcast